We have included Hansard in our Conviction list because we believe that the valuation is hugely compelling and that the Q3 sales update on 12th May will act as a trigger for the shares. In our view the sales outlook is key to the business going forward and we believe that another strong performance (H1 sales +92% including Q2 +136%) will reinforce our view that a corner has been turned. Unlike other insurers concerns over Brexit are unlikely to have a negative impact and indeed the weakness o ....